Long-term follow-up after blood and cellular transplants
Core D: Long-Term Follow-Up
['FUNDING_P01'] · FRED HUTCHINSON CANCER CENTER · NIH-11177719
This program keeps track of people who had hematopoietic cell transplants or cellular immunotherapy to monitor health and collect long-term data.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11177719 on ClinicalTrials.gov |
What this research studies
If you had a bone marrow/stem cell transplant or cellular immunotherapy at Fred Hutch, University of Washington, or Seattle Children’s, this core helps keep in touch and gathers health information and research samples for years after treatment. Staff maintain scheduled contact with patients and referring physicians to collect data on survival, therapy-related complications, and overall health at specified time points. The core also helps investigators obtain extra research biospecimens that are not routinely collected and enters all information into a secure database that is checked for quality and usefulness. These services support Projects 2 and 3 by identifying and managing late complications and improving the research data available about long-term outcomes.
Who could benefit from this research
Good fit: People who received hematopoietic cell transplantation or cellular immunotherapy at Fred Hutch, University of Washington, or Seattle Children’s Hospital and who can be followed over the long term are the ideal candidates.
Not a fit: People who never had HCT or cellular immunotherapy, who were treated elsewhere without available records, or who cannot commit to long-term contact or sample sharing are unlikely to benefit.
Why it matters
Potential benefit: This could help spot and manage late complications earlier and improve long-term care and future treatments for transplant survivors.
How similar studies have performed: Long-term follow-up registries for transplant patients have already helped uncover late effects and guide survivorship care, so this builds on proven approaches.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEE, STEPHANIE J — FRED HUTCHINSON CANCER CENTER
- Study coordinator: LEE, STEPHANIE J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center, Cancers